Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key Player
{{output}}
Alzheimer's disease (AD) represents the most common cause of dementia in the elderly population worldwide. However, most of the anti-AD medications did not resolve the underlying neuropathology. Consequently, targeting other signaling pathways may be helpful ... ...
